Jump Financial »

Phathom Pharmaceuticals shares owned by Jump Financial

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $289k 17k 16.59

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares 20 Year Treasury Bond ETF Etf (TLT)
NVIDIA Corp Common Stock (NVDA)
Walmart Common Stock (WMT)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)
Alibaba Group Holding Convertible bond (Principal)
Boston Scientific Corp Common Stock (BSX)
Energy Transfer Partnership Shares (ET)

View all positions for Jump Financial

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Millennium Management
Invesco
BlackRock
Carlyle
Vanguard Group
Ensign Peak Advisors
NEA Management Company
683 Capital Management
Catalys Pacific
Daniel D. Thurber
Jennifer Ranahan
State Street Corporation
Geode Capital Management

View all funds holding Phathom Pharmaceuticals